Alzheimer’s disease Archives - Express Pharma

Machine learning model developed to predict brain amyloid beta accumulation

Global Alzheimer’s disease market to reach $19.3 bn in 8MM by 2033

Elucidation of part of the mechanism by which Lecanemab slows the progression of Alzheimer’s

Biomarkers becoming important for approval of ALS therapies: GlobalData

Exploring new avenues to treat Alzheimer’s

When proteins get stuck at solid: Unlocking the secrets to brain diseases

Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease

USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment

Biogen gets US FDA accelerated approval for Aduhelm to treat Alzheimer’s

Re-purposed drugs could reverse blood vessel damage in diabetes